beta-thujaplicin has been researched along with Pneumonia, Pneumococcal in 1 studies
beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.
Pneumonia, Pneumococcal: A febrile disease caused by STREPTOCOCCUS PNEUMONIAE.
Excerpt | Relevance | Reference |
---|---|---|
"Antibiotics are the primary line of treatment for pneumococcal pneumonia; however, rising antimicrobial resistance is becoming more prevalent." | 1.56 | Treatment of severe pneumonia by hinokitiol in a murine antimicrobial-resistant pneumococcal pneumonia model. ( Domon, H; Hiyoshi, T; Isono, T; Kunitomo, E; Maekawa, T; Nagai, K; Noiri, Y; Takenaka, S; Tamura, H; Terao, Y; Yanagihara, K, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Isono, T | 1 |
Domon, H | 1 |
Nagai, K | 1 |
Maekawa, T | 1 |
Tamura, H | 1 |
Hiyoshi, T | 1 |
Yanagihara, K | 1 |
Kunitomo, E | 1 |
Takenaka, S | 1 |
Noiri, Y | 1 |
Terao, Y | 1 |
1 other study available for beta-thujaplicin and Pneumonia, Pneumococcal
Article | Year |
---|---|
Treatment of severe pneumonia by hinokitiol in a murine antimicrobial-resistant pneumococcal pneumonia model.
Topics: Animals; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Chemokine CXCL1; Cytokines; Drug Resis | 2020 |